×
For more information, get in touch with our team:
+44 7918 53 08 73
Hint mode is switched on Switch off
Register
to order full access
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 500,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 100 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

S&P Global Ratings downgrades Foreign Currency LT credit rating of AMAG Pharmaceutical to "B"; outlook stable

February 1, 2018
S&P Global Ratings downgraded from "B+" to "B" the Foreign Currency LT credit rating of AMAG Pharmaceutical on January 30, 2018. The outlook is stable.
Company — AMAG Pharmaceuticals
  • Full name
    AMAG Pharmaceuticals, Inc.
  • Registration country
    USA
  • Industry
    Healthсare

Other Company's News

Copyright (c) 2004-2021 CbondS